Hematological and neurological expressed 1 (HN1) activates c-Myc signaling by inhibiting ubiquitin-mediated proteasomal degradation of c-Myc in hepatocellular carcinoma.

Feng, Jutao; Liu, Yanmin; Fang, Tianling; Zhu, Jinrong; Wang, Guoying; Li, Jun

Feng, Jutao; Liu, Yanmin; Fang, Tianling; Zhu, Jinrong; Wang, Guoying; Li, Jun.

Afiliação

Feng J; Hepatobiliary Surgery Department, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Liu Y; Hepatobiliary Surgery Department, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Fang T; Hepatobiliary Surgery Department, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Zhu J; Guangdong Province Key Laboratory for Biotechnology Drug Candidates, School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, China.
Wang G; Hepatobiliary Surgery Department, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Li J; Hepatobiliary Surgery Department, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Cell Biol Int ; 47(3): 560-572, 2023 Mar.

Article em En | MEDLINE | ID: mdl-36403281

Assuntos

Carcinoma Hepatocelular; Neoplasias Hepáticas; Humanos; Carcinoma Hepatocelular/metabolismo; Linhagem Celular Tumoral; Proliferação de Células/genética; Regulação Neoplásica da Expressão Gênica; Genes myc; Neoplasias Hepáticas/metabolismo; Proteínas Proto-Oncogênicas c-myc/metabolismo; Transdução de Sinais; Ubiquitina/metabolismo

Palavras-chave

HN1; MYC; hepatocellular carcinoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google